Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
Public ClinicalTrials.gov record NCT05535738. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Biologics and Blistering - Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation Through Suction Blistering
Study identification
- NCT ID
- NCT05535738
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Wei-Che Ko
- Other
- Enrollment
- 45 participants
Conditions and interventions
Conditions
Interventions
- Adalimumab Drug
- Betamethasone Valerate Drug
- Canakinumab Drug
- Dupilumab Drug
- Fluticasone Propionate Drug
- Guselkumab Drug
- Known patch test allergens Other
- Microneedle Device
- Sarilumab Drug
- Skin punch biopsy Procedure
- Squaric Acid Dibutyl Ester Drug
- Suction blistering Device
- Triamcinolone Acetonide Drug
- Ustekinumab Drug
Drug · Other · Device + 1 more
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 14, 2022
- Primary completion
- Dec 31, 2026
- Completion
- Dec 30, 2027
- Last update posted
- May 13, 2026
2022 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Massachusetts Chan Medical School | Worcester | Massachusetts | 01605 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05535738, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05535738 live on ClinicalTrials.gov.